Kendra Wulczyn, MD
Enriched profileInstructor in Medicine, Nephrology Division, Mass General Hospital and Harvard Medical School · Massachusetts General Hospital
Kendra Wulczyn is Instructor in Medicine, Nephrology Division, Mass General Hospital and Harvard Medical School at Massachusetts General Hospital. OpenAlex indexes 28 publications with 1,082 citations (h-index 8); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 28 Oct 2026
Overview
Updated 28 Oct 2026
Kendra Wulczyn, MD, is Instructor in Medicine, Nephrology Division, Mass General Hospital and Harvard Medical School at Massachusetts General Hospital (Mass General Brigham). The public record shows 28 publications with 1,082 citations (h-index 8), centered on Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Metabolomics and Mass Spectrometry Studies. It also documents an investigator role on 1 registered clinical trials, 2 NIH-funded awards (2022–2026).
- Most recent indexed publication: 2026 · Kidney360
- Top research focus: Dialysis and Renal Disease Management
- 1 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 6.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease
Sponsor: Massachusetts General Hospital
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
64.4%ACE inhibitor31.1%Lisinopril100%Part D<11 patientsLoop diuretic17.8%Torsemide100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
35.6%SGLT2 inhibitor35.6%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 28 Oct 2026
2 NIH research awards on record, funded 2022–2026 per NIH RePORTER. The latest:
- Patient-Reported Outcome Measure (PROM) Utilization to Advance Patient Centered CKD Care
Massachusetts General Hospital
FY2026$197,474K23DK140642 - Patient-Reported Outcome Measure (PROM) Utilization to Advance Patient Centered CKD Care
Massachusetts General Hospital
FY2025$199,130K23DK140642 - Determinants of Uremic Symptoms in CKD and Associations to Clinical Outcomes
Massachusetts General Hospital
FY2023$47,402F32DK131793
Publications
Updated 28 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Incidence and Risk Factors for Pruritus in Patients with Nondialysis CKD.
Clinical journal of the American Society of Nephrology
Article2023 - Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease.
Clinical journal of the American Society of Nephrology
Article2022
Most-cited works
by citation count (OpenAlex)- 01Gonadal Steroids and Body Composition, Strength, and Sexual Function in MenArticle784 citations2013
- 02Thyroid Function in the Euthyroid Range and Adverse Outcomes in Older AdultsArticle201 citations2014
- 03
- 04Incidence and Risk Factors for Pruritus in Patients with Nondialysis CKDArticle19 citations2022
- 05
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 28 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/kendra-wulczyn-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 28 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchers.mgh.harvard.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
Secondary affiliations
appointments beyond the home institution- Research Fellow in Medicine (external)
Harvard Medical School
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchers.mgh.harvard.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Keith Flaherty, MD
Massachusetts General Hospital
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)